Harvesting from Forest

A pair of former Forest Laboratories Inc. alumni have founded specialty respiratory company Acton Pharmaceuticals Inc. around Aerospan flunisolide, a product they in-licensed from Forest (NYSE: FRX).

FDA approved Aerospan to treat asthma in 2006, but Forest never launched the product. Acton President Daniel Kreisler, who held various titles at Forest including director of business development and new product marketing and director of marketing, said the company shelved the product because the market was too small and didn't align with its strategy...